Expert Ratings for Adagene

Adagene (NASDAQ:ADAG) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

Adagene (NASDAQ:ADAG) has observed the following analyst ratings within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 1 0 0 0
Last 30D 1 0 0 0 0
1M Ago 1 0 0 0 0
2M Ago 1 0 0 0 0
3M Ago 0 1 0 0 0

In the last 3 months, 4 analysts have offered 12-month price targets for Adagene. The company has an average price target of $5.0 with a high of $5.00 and a low of $5.00.

Below is a summary of how these 4 analysts rated Adagene over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

price target chart

This current average has decreased by 28.57% from the previous average price target of $7.00.

Stay up to date on Adagene analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Analyst Ratings: What Are They?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish “analyst ratings” for stocks. Analysts typically rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Expert Ratings for ShockWave Medical

Over the past 3 months, 5 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

SWAV

Read More

4 Retail Stocks Downgraded, But 3 Are Best Positioned: Why UBS Has A Bearish View

Analysts at UBS are bearish on several U.S. retail stocks. A predicted consumer spending slowdown will trickle down to the industry’s earnings for the remainder of the year, they said. Jay Sole downgraded five U.S. retail stocks and lowered 2023 calendar year estimates by 10%. The five stocks downgraded from a Neutral rating to Sell:

BBWI